ApprovalTrail

Approval · Notice of Compliance 10078 · 2009

NOROCARP CAPLETS: Notice of Compliance 10078

Issued March 9, 2009

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
10078
Date
March 9, 2009
Company
Norbrook Laboratories Ltd.Newry, Northern Ireland, United Kingdom
Product type
Veterinary
Submission
Abbreviated New Drug Submission (ANDS)
Submission class
Other
Therapeutic class
Non-steroidal anti-inflammatory
Canadian reference product
RIMADYL CAPLETS (Pfizer Canada Ulc)

Products in this notice

BrandDINStatus today
NOROCARP CAPLETS02320657Cancelled Post Market

Medicinal ingredients